Total Body Digital Skin Imaging System Developed for Dermatology and Primary Care Practices

The DermSpectra (Tucson, AZ, USA) medical technology advances the way physicians digitally capture and compare skin irregularities by rapidly delivering patented high-resolution imaging, HIPPA (Health Insurance Portability and Accountability Act of 1996)-compliant secure storage, and immediate viewing capabilities.

For use by patients, dermatology and primary care practices, telemedicine centers, cosmetic and plastic surgeons, and the medical community, DermSpectra fulfills a crucial gap in the digital skin imaging (DSI) market. Currently, there are few tools for standardized screening to aid in early detection of skin cancer at the total body level.

Using the system, patients experience an in-office private, convenient, and short imaging session (8–10 minutes) while their physician views the latest digital images (on desktop or iPad), annotates directly to the image, and stores them securely on a HIPPA-compliant server database. DermSpectra total body digital skin imaging enables physicians to complete the physical exam, assessment, and plan care during one office visit, lessening post-appointment documentation. The Apple (Cupertino, CA, USA) Store recently approved the DermSpectra viewing application, which is now available by physicians to view stored images.

Digital images captured through DermSpectra can be marked using simple touch screen features that allow physicians to zoom in on lesions, circle abnormalities or changes, add notes, annotate directly on the image, and attach a report to the patient’s electronic medical record (EMR). Ultimately this will move the field of dermatological assessment into an imagecentric-based practice.

According to Dr. Richard Carmona, 17th US Surgeon General and DermSpectra board member, “DermSpectra is setting the industry standard for how future dermatology, primary care, and medical practices will capture image data to assist early detection of melanoma and other skin diseases. With skin cancer incidence and treatment costs on the rise, DermSpectra is filling an imaging gap to aid in preventative skin screening.”

“DermSpectra total body digital skin imaging has been in beta testing since September 2013, most recently at Southwest Skin Specialists in Scottsdale, Arizona [USA] and University of Arizona Cancer Center in Tucson, Arizona, and is scheduled for installation at Mayo Clinic,” stated Karleen Seybold, co-founder and chief executive officer of DermSpectra. “Successful beta tests showed that 86% of participants reported being very satisfied with their DermSpectra experience and 88% said total body imaging is very important to the quality of medical care. DermSpectra is changing the way the industry and public thinks about preventative skin imaging and will standardize the way skin changes are tracked and monitored over time.”

The DermSpectra total body digital skin imaging system is a proprietary solution that provides patented high-resolution imaging, secure storage, and immediate viewing capabilities.

Related Links:
DermSpectra